Pharmacokinetic Study of Two HIV Protease Inhibitors in Patients
Status:
Terminated
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the pharmacokinetics of lopinavir, ritonavir, and
atazanavir when lopinavir/ritonavir and atazanavir are used in combination.
Phase:
Phase 4
Details
Lead Sponsor:
University of Oklahoma
Collaborator:
Abbott
Treatments:
Atazanavir Sulfate HIV Protease Inhibitors Lopinavir Protease Inhibitors Ritonavir